---
title: Cellares vs Scinai Immunotherapeutics Ltd.
slug_a: cellares
slug_b: scinai-immunotherapeutics
site: cdmo
review_signal_gate: closed
canonical_path: /compare/cellares/scinai-immunotherapeutics
---

# Cellares vs Scinai Immunotherapeutics Ltd.

Side-by-side profile data from each company listing on this directory.

## Cellares

- Profile: [/companies/cellares](/companies/cellares)

Cellares — Cellares operates a global network of Smart Factories delivering integrated development and manufacturing (IDMO) services for cell therapies, with proprietary Cell Shuttle® and Cell Q™ platforms enabling cGMP-compliant, automated manufacturing and quality control at clinical and commercial scale.

Services: 8. Modalities: 1. Indications: 0. Locations: 4. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- CMC Regulatory Submission Support

### Modalities

- Cell Therapy

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)

## Scinai Immunotherapeutics Ltd.

- Profile: [/companies/scinai-immunotherapeutics](/companies/scinai-immunotherapeutics)

Scinai Immunotherapeutics Ltd. — Boutique biologics CDMO providing analytical method development, process development, and cGMP manufacturing for biotech clients from early research through Phase 3, backed by over 20 years of experience and state-of-the-art facilities.

Services: 6. Modalities: 1. Indications: 3. Locations: 2. Certifications: 2. The strongest documented coverage currently appears in services (6).

### Services

- Biologics Development & Manufacturing
- Recombinant Protein Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Biologics (Monoclonal Antibodies)

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Expression: Mammalian